Aspirin resistance after coronary artery bypass grafting
- 1 May 2001
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 121 (5) , 982-984
- https://doi.org/10.1067/mtc.2001.111416
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- 40 mg of Aspirin Are Not Sufficient to Inhibit Platelet Function under Conditions of Limited ComplianceThrombosis Research, 2000
- Cyclooxygenase-2 in human platelets as a possible factor in aspirin resistanceThe Lancet, 1999
- Platelets and cardiopulmonary bypassPerfusion, 1998
- Aortocoronary Saphenous Vein Graft DiseaseCirculation, 1998
- Aspirin and Platelets: The Antiplatelet Action of Aspirin and Its Role in Thrombosis Treatment and ProphylaxisSeminars in Thrombosis and Hemostasis, 1997
- Variability in the Pharmacokinetics and Pharmacodynamics of Low Dose Aspirin in Healthy Male VolunteersThe Journal of Clinical Pharmacology, 1995
- Antithrombotic Therapy in Patients With Saphenous Vein and Internal Mammary Artery Bypass GraftsChest, 1995
- Aspirin in Cardiovascular DiseaseDrugs, 1988
- The biochemical pharmacology of thromboxane synthase inhibition in man.Circulation, 1985